Mitochondria and immunity in chronic fatigue syndrome.
Anderson, G, Maes, M · Progress in neuro-psychopharmacology & biological psychiatry · 2020 · DOI
Quick Summary
This review examines how problems with energy-producing structures in cells (mitochondria) and immune system dysfunction may contribute to ME/CFS. The authors propose that two key areas—the gut and immune cells—work together with the body's natural sleep-wake cycle to drive the condition. They also explore how factors like viral infections, gut bacteria, and hormones may play interconnected roles in ME/CFS symptoms.
Why It Matters
Understanding how different biological systems interact in ME/CFS could lead to better explanations for why patients experience such diverse symptoms and guide development of targeted treatments. This integrated perspective may also help researchers understand other complex conditions like fibromyalgia and depression that share similar features with ME/CFS.
Observed Findings
Mitochondrial dysfunction is observed across multiple cell types in ME/CFS, including immune cells
Gut permeability and microbiome alterations are frequently reported in ME/CFS patients
Circadian rhythm disruption and sleep abnormalities are common features
Immune activation markers and viral reactivation have been documented in cohort studies
Multiple neuroendocrine systems show dysregulation including opioidergic and leptin signaling
Inferred Conclusions
Gut and immune cell mitochondria represent central pathophysiological hubs in ME/CFS
Circadian rhythm disruption may drive or perpetuate mitochondrial and immune dysfunction
ME/CFS likely involves complex interactions between multiple biological systems rather than single mechanisms
Targeting these interconnected systems may offer therapeutic opportunities superior to single-target approaches
Remaining Questions
Which identified mechanisms are primary drivers of ME/CFS versus secondary consequences of the illness?
Do the proposed interactions between mitochondrial, immune, and circadian systems differ significantly between ME/CFS patient subgroups?
What This Study Does Not Prove
This review does not provide experimental evidence that any proposed mechanism actually causes ME/CFS—it synthesizes existing literature to suggest plausible interactions. It cannot establish which factors are primary drivers versus secondary consequences, and correlation between findings in different studies does not prove causation. Clinical trials would be needed to validate whether targeting these mechanisms actually improves patient outcomes.